NCT01909986View on ClinicalTrials.gov

A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Conditions
Healthy Adult Male Subjects
Interventions
DRUG

[14C]ONO-4053

Single dose \[14C\]ONO-4053

Trial Locations (1)

NG11 6JS

Nottingham Clinical site, Nottingham

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY

NCT01909986 - A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053 | Biotech Hunter | Biotech Hunter